Latest Commercialization News

Inghams Group delivered modest revenue growth in FY26 but saw net profit collapse amid cost pressures and tax disputes. Executive short-term incentives were forfeited, while the company declared a fully franked dividend and outlined a cautious FY27 outlook.

Noble Helium is set to acquire Earth Source Hydrogen, gaining control of 40,000 square kilometres of helium prospective acreage in Western Australia’s Southern Carnarvon Basin. This strategic move complements its Tanzania project and positions the company to tap into growing global helium demand.

American Tungsten & Antimony Ltd (ASX: AT4) has kicked off critical wet table trials at its Del Sol Refinery in Nevada, moving closer to producing ammonium paratungstate and antimony flake from domestic sources. Engineering proposals for expanding the plant’s tungsten processing capacity are under review, while the company pursues US government funding and regulatory approvals.

Elevra Lithium has secured a binding seven-year supply agreement with Mangrove Lithium for spodumene concentrate from its North American Lithium site, anchoring a key feedstock for Mangrove’s planned Canadian lithium conversion facility.

Guzman y Gomez (ASX: GYG) reported strong FY26 growth with network sales rising 18% and underlying NPAT up 30%, while completing its exit from the US market and announcing a 48 cents fully franked dividend.

Aurora Labs posted a 36% increase in net loss to $5.1 million for FY2026 despite securing key defence contracts and partnerships. The company is transitioning from R&D to early commercialisation of its micro gas turbine propulsion systems, backed by a $5.5 million capital raise and government grants.

James Hardie Industries has agreed to divest its European Fermacell sustainable walling and flooring business to Holcim for €840 million, while planning to close its European fiber cement operations and launch a $250 million share buyback.

Ramelius Resources delivered 192,182 ounces of gold in FY26, meeting guidance for the sixth year, while integrating the Spartan acquisition and advancing key projects including the Rebecca-Roe DFS and Mt Magnet plant upgrade.

Regis Resources (ASX:RRL) delivered a landmark FY26 with a 181% surge in net profit to $715 million, underpinned by strong gold production and record prices. The company declared a fully franked 35 cents per share dividend, including a special 5 cents payout from the terminated Vault Minerals merger break fee.

Medallion Metals has raised A$60 million through a targeted placement, boosting its liquidity to about A$175 million and enabling accelerated development of its Ravensthorpe Gold Project and drilling programs in Western Australia.

Pacific Edge’s draft Medicare Local Coverage Determination for its Cxbladder bladder cancer tests marks a pivotal step toward unlocking a $10.2 billion global market. Despite FY26 setbacks, the company is poised for growth with improved reimbursement prospects and strategic cost management.

Parkway Corporate has cleared major regulatory hurdles for its Queensland Brine Management Complex, the first Australian facility authorised to convert coal seam gas waste brine into industrial chemicals, setting a new benchmark in sustainable waste management.